Tilray Brands Inc
For the period ended Feb 29, 2024. Filed Apr 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Feb 29, 2024 · Filed Apr 9, 2024
TLRY$2.65-7.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders' Equity (Unaudited)
Consolidated Statements of Stockholders’** Equity**
(in thousands of United States dollars, except for share data, unaudited)
| Accumulated | |||||||
|---|---|---|---|---|---|---|---|
| Number of · Additional · other · Non- | |||||||
| common · Common · paid-in · comprehensive · Accumulated · controlling | |||||||
| shares | stock | capital | loss | Deficit | interests | Total | |
| Balance at May 31, 2022 | 532,674,887 | $53 | $5,382,367 | $(20,764) | $(962,851) | $42,561 | $4,441,366 |
| Share issuance - equity financing | 32,481,149 | 3 | 129,590 | — | — | — | 129,593 |
| Shares issued to purchase HEXO convertible note receivable | 33,314,412 | 3 | 107,269 | — | — | — | 107,272 |
| HTI Convertible Note - conversion feature | — | — | 9,055 | — | — | — | 9,055 |
| Share issuance - Double Diamond Holdings dividend settlement | 1,529,821 | 1 | 5,063 | — | — | — | 5,064 |
| Share issuance - options exercised | 3,777 | — | — | — | — | — | — |
| Share issuance - RSUs exercised | 950,893 | — | — | — | — | — | — |
| Shares effectively repurchased for employee withholding tax | — | — | (1,189) | — | — | — | (1,189) |
| Stock-based compensation | — | — | 9,193 | — | — | — | 9,193 |
| Dividends declared to non-controlling interests | — | — | — | — | — | (8,561) | (8,561) |
| Comprehensive income (loss) for the period | — | — | — | (58,968) | (73,482) | 3,839 | (128,611) |
| Balance at August 31, 2022 | 600,954,939 | 60 | 5,641,348 | (79,732) | (1,036,333) | 37,839 | 4,563,182 |
| Shares issued to purchase Montauk | 1,708,521 | — | 6,422 | — | — | — | 6,422 |
| Share issuance - options exercised | 4,183 | — | — | — | — | — | — |
| Share issuance - RSUs exercised | 237,611 | — | — | — | — | — | — |
| Stock-based compensation | — | 10,943 | — | — | — | 10,943 | |
| Share issuance - Double Diamond Holdings dividend settlement | 10,276,305 | 1 | 38,753 | — | — | (32,280) | 6,474 |
| Comprehensive income (loss) for the period | — | — | (41,723) | (69,463) | 7,311 | (103,875) | |
| Balance at November 30, 2022 | 613,181,559 | 61 | 5,697,466 | (121,455) | (1,105,796) | 12,870 | 4,483,146 |
| Share issuance - RSUs exercised | 487,192 | — | — | — | — | — | — |
| Stock-based compensation | — | — | 9,630 | — | — | — | 9,630 |
| Share issuance - Double Diamond Holdings dividend settlement | 4,188,280 | 1 | 15,912 | — | — | (8,235) | 7,678 |
| Preferred share issuance | 120,000 | — | 334 | — | — | — | 334 |
| Comprehensive income (loss) for the period | — | — | — | 78,507 | (1,170,998) | (1,526) | (1,094,017) |
| Balance at February 28, 2023 | 617,977,031 | $62 | $5,723,342 | $(42,948) | $(2,276,794) | $3,109 | $3,406,771 |
| Balance at May 31, 2023 | 656,655,455 | $66 | $5,777,743 | $(46,610) | $(2,415,507) | $14,251 | $3,329,943 |
| Share issuance - HEXO acquisition | 39,705,962 | 4 | 65,158 | — | — | — | 65,162 |
| Share issuance - settlement of contractual change of control severance incurred from HEXO acquisition | 865,426 | — | 1,500 | — | — | — | 1,500 |
| Share issuance - Double Diamond Holdings dividend settlement | 5,004,735 | — | 8,146 | — | — | — | 8,146 |
| Share issuance - HTI convertible note | 17,148,541 | 2 | 49,998 | 50,000 | |||
| Share issuance - RSUs exercised | 3,912,481 | — | — | — | — | — | — |
| Shares effectively repurchased for employee withholding tax | — | — | (4,860) | — | — | — | (4,860) |
| Equity component related to issuance of convertible debt, net of issuance costs | — | — | 3,953 | — | — | — | 3,953 |
| Stock-based compensation | — | — | 8,257 | — | — | — | 8,257 |
| Dividends declared to non-controlling interests | — | — | — | — | — | (7,891) | (7,891) |
| Comprehensive income (loss) for the period | — | — | — | 3,049 | (71,525) | 15,822 | (52,654) |
| Balance at August 31, 2023 | 723,292,600 | 72 | 5,909,895 | (43,561) | (2,487,032) | 22,182 | 3,401,556 |
| Share issuance - HTI convertible note | 1,032,616 | — | 2,313 | — | — | — | 2,313 |
| Share issuance - Settlement of litigation claims from MediPharm Labs Inc | 1,573,152 | — | 3,477 | — | — | — | 3,477 |
| Share issuance - Repurchase of TLRY 23 convertible note | 7,000,000 | 1 | 20,457 | — | — | — | 20,458 |
| Share issuance - Settlement of equity component of TLRY 23 convertible note | — | — | (1,672) | — | — | — | (1,672) |
| Share issuance - RSUs exercised | 9,184 | — | — | — | — | — | — |
| Stock-based compensation | — | — | 8,201 | — | — | — | 8,201 |
| Comprehensive income (loss) for the period | — | — | — | 5,194 | (49,008) | 2,834 | (40,980) |
| Balance at November 30, 2023 | 732,907,552 | 73 | 5,942,671 | (38,367) | (2,536,040) | 25,016 | 3,393,353 |
| Share issuance - Repurchase of APHA 24 convertible note | 27,228,252 | 3 | 51,380 | — | — | — | 51,383 |
| Share issuance - Double Diamond Holdings dividend settlement | 13,627,391 | 1 | 28,599 | — | — | (26,217) | 2,383 |
| Share issuance - RSUs exercised | 260,567 | — | — | — | — | — | — |
| Share issuance - options exercised | 4,291 | — | — | — | — | — | — |
| Stock-based compensation | — | — | 8,059 | — | — | — | 8,059 |
| Dividends declared to non-controlling interests | — | — | — | — | — | (2,458) | (2,458) |
| Comprehensive income (loss) for the period | — | — | — | (4,820) | (92,701) | (12,158) | (109,679) |
| Balance at February 29, 2024 | 774,028,053 | $77 | $6,030,709 | $(43,187) | $(2,628,741) | $(15,817) | $3,343,041 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.